rituximab
Interviews and expert commentary tagged “rituximab” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology in Advance – March 15th, 2008
Volume 16 Number 6 (March 15th, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) American Society of Hematology Annual Meeting (December 8-11, 2007
Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
Timothy Illidge Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 TIMOTHY ILLIDGE, Christie Hospital, Manchester Radioconjugated antibodies are showing grea
ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando
Francis Giles Ken Kaushansky Heather Leitch Nancy Berliner Corrado Tarella Vincent Rajkumar Robert Kyle Aurora Kinase BCR-ABL Inhibitor Beats T315-I Mutation in Patients with Chronic Myeloid Leukemia
Dec. 15, 2006: Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006
Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Respo
Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma
Sandra Horning Abstract 349 Sandra Horning, Stanford University Medical Center It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therap